[go: up one dir, main page]

DK1077935T3 - Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer - Google Patents

Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer

Info

Publication number
DK1077935T3
DK1077935T3 DK99919771T DK99919771T DK1077935T3 DK 1077935 T3 DK1077935 T3 DK 1077935T3 DK 99919771 T DK99919771 T DK 99919771T DK 99919771 T DK99919771 T DK 99919771T DK 1077935 T3 DK1077935 T3 DK 1077935T3
Authority
DK
Denmark
Prior art keywords
phenylethylamines
phenylsulfonamide
alkyl
dopamine receptors
nhcoch3
Prior art date
Application number
DK99919771T
Other languages
Danish (da)
English (en)
Inventor
Arthur Glenn Romero
Jeffrey A Leiby
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1077935T3 publication Critical patent/DK1077935T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99919771T 1998-05-14 1999-05-07 Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer DK1077935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (1)

Publication Number Publication Date
DK1077935T3 true DK1077935T3 (da) 2004-02-16

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99919771T DK1077935T3 (da) 1998-05-14 1999-05-07 Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer

Country Status (25)

Country Link
US (1) US6103766A (ru)
EP (1) EP1077935B1 (ru)
JP (1) JP2002514623A (ru)
KR (1) KR20010043546A (ru)
CN (1) CN1152857C (ru)
AT (1) ATE253045T1 (ru)
AU (1) AU752543B2 (ru)
BR (1) BR9910405A (ru)
CA (1) CA2327345A1 (ru)
DE (1) DE69912419T2 (ru)
DK (1) DK1077935T3 (ru)
EA (1) EA002918B1 (ru)
ES (1) ES2211078T3 (ru)
HK (1) HK1036049A1 (ru)
HU (1) HUP0101746A3 (ru)
IL (1) IL139263A0 (ru)
NO (1) NO20005732L (ru)
NZ (1) NZ508152A (ru)
PL (1) PL343891A1 (ru)
PT (1) PT1077935E (ru)
SK (1) SK16242000A3 (ru)
TR (1) TR200003325T2 (ru)
TW (1) TW450954B (ru)
WO (1) WO1999058499A1 (ru)
ZA (1) ZA200005921B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2276278C (en) * 1997-02-27 2009-04-07 Takeda Chemical Industries, Ltd. Amine compounds, their production and use
JP2004535390A (ja) * 2001-05-07 2004-11-25 スミスクライン・ビーチャム・コーポレイション スルホンアミド
WO2002089740A2 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
CA2583333C (en) 2004-10-14 2013-05-14 Abbott Gmbh & Co. Kg Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
US8232426B2 (en) 2004-10-14 2012-07-31 Abbott Gmbh & Co. Kg Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
TWI364414B (en) 2004-10-14 2012-05-21 Abbott Gmbh & Co Kg Phenylpyrrolidine dopamine d3 receptor antagonists
UY30284A1 (es) 2006-04-14 2007-11-30 Abbott Gmbh & Amp Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3
DE602007012071D1 (de) * 2006-04-14 2011-03-03 Abbott Gmbh & Co Kg Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen
NZ572761A (en) 2006-04-19 2011-09-30 Abbott Gmbh & Co Kg Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
CA2648892A1 (en) 2006-04-19 2007-10-25 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
AU4368996A (en) * 1994-11-23 1996-06-17 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
KR20000010905A (ko) * 1996-05-11 2000-02-25 피터 기딩스 도파민 d3 수용체의 조절제로서의 테트라히드로이소퀴놀린유도체
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体

Also Published As

Publication number Publication date
EA002918B1 (ru) 2002-10-31
JP2002514623A (ja) 2002-05-21
NO20005732D0 (no) 2000-11-13
EA200001184A1 (ru) 2001-04-23
NZ508152A (en) 2003-03-28
KR20010043546A (ko) 2001-05-25
AU752543B2 (en) 2002-09-19
EP1077935B1 (en) 2003-10-29
ES2211078T3 (es) 2004-07-01
NO20005732L (no) 2000-11-13
US6103766A (en) 2000-08-15
EP1077935A1 (en) 2001-02-28
ATE253045T1 (de) 2003-11-15
BR9910405A (pt) 2001-01-09
HUP0101746A3 (en) 2002-10-28
PT1077935E (pt) 2004-03-31
CA2327345A1 (en) 1999-11-18
SK16242000A3 (sk) 2001-06-11
PL343891A1 (en) 2001-09-10
WO1999058499A1 (en) 1999-11-18
CN1297431A (zh) 2001-05-30
TR200003325T2 (tr) 2001-04-20
HK1036049A1 (en) 2001-12-21
DE69912419D1 (de) 2003-12-04
HUP0101746A2 (hu) 2002-03-28
ZA200005921B (en) 2001-11-14
DE69912419T2 (de) 2004-07-22
AU3741899A (en) 1999-11-29
IL139263A0 (en) 2001-11-25
CN1152857C (zh) 2004-06-09
TW450954B (en) 2001-08-21

Similar Documents

Publication Publication Date Title
DK1077935T3 (da) Phenylsulfonamid-phenylethylaminer, der kan anvendes som dopamin-receptorer
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
YU56301A (sh) Inhibitori resorpcije monoamina za tretiranje poremećaja cns
PE20031011A1 (es) Derivados de dihidrobenzodiazepin-2-ona-iii
NO973532L (no) 2-aminoindaner som selektive dopamin D3-ligander
NO20032253L (no) Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer
HRP20030003B1 (en) N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
DK1235776T3 (da) Triphenylalkenderivater og deres anvendelse som selektive östrogenreceptormodulatorer
NO20001400L (no) Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist
DE60003899D1 (de) Aryl-annellierte disubstituierte pyridine : nk3 rezeptor-liganden
BR9908321A (pt) Composto
PE20021003A1 (es) Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri)
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
ATE157977T1 (de) Chinoxalinderivate als eaa antagonisten
PE20060632A1 (es) Derivados de arilsulfonilestilbeno como antagonistas de los receptores 5-ht2a
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
PE20030540A1 (es) Derivados de amidas de acido antranilico como inhibidores del receptor de tirosina quinasa de vegf
PE20040788A1 (es) Derivados de indol con afinidad al receptor de androgeno
AR009786A1 (es) Pirrolcarboxamidas fusionadas, una nueva clase de ligandos receptores cerebrales gaba